ArticleBritish journal of cancer2019
The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer.
Liesa-Marie Schreiber et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papercites it